VENTURA, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.004
EU - Europa 18.006
AS - Asia 10.520
SA - Sud America 1.515
Continente sconosciuto - Info sul continente non disponibili 296
AF - Africa 210
OC - Oceania 42
Totale 52.593
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.538
IT - Italia 5.876
GB - Regno Unito 4.836
SG - Singapore 3.044
SE - Svezia 2.831
CN - Cina 2.820
BR - Brasile 1.151
HK - Hong Kong 1.142
DE - Germania 1.080
VN - Vietnam 1.065
BD - Bangladesh 646
FI - Finlandia 637
FR - Francia 632
UA - Ucraina 568
TR - Turchia 401
RU - Federazione Russa 397
KR - Corea 353
NL - Olanda 314
IN - India 283
CA - Canada 262
BG - Bulgaria 178
ID - Indonesia 143
AR - Argentina 135
MX - Messico 108
PL - Polonia 102
IQ - Iraq 89
JP - Giappone 81
BE - Belgio 80
ZA - Sudafrica 75
ES - Italia 72
IE - Irlanda 69
MY - Malesia 58
AE - Emirati Arabi Uniti 53
EC - Ecuador 47
CO - Colombia 46
CH - Svizzera 43
RO - Romania 43
LT - Lituania 40
VE - Venezuela 37
AT - Austria 36
CL - Cile 36
CZ - Repubblica Ceca 36
AU - Australia 35
PH - Filippine 33
PK - Pakistan 32
UZ - Uzbekistan 30
SA - Arabia Saudita 27
IR - Iran 23
JO - Giordania 23
PE - Perù 23
MA - Marocco 22
PY - Paraguay 21
AZ - Azerbaigian 20
JM - Giamaica 20
DZ - Algeria 19
EG - Egitto 19
GR - Grecia 19
IL - Israele 19
NP - Nepal 19
PT - Portogallo 19
NO - Norvegia 16
TH - Thailandia 16
CR - Costa Rica 15
TN - Tunisia 15
TW - Taiwan 15
KE - Kenya 14
AL - Albania 12
EU - Europa 12
BO - Bolivia 11
KG - Kirghizistan 11
BH - Bahrain 10
GT - Guatemala 10
TT - Trinidad e Tobago 10
RS - Serbia 9
SY - Repubblica araba siriana 9
DK - Danimarca 8
DO - Repubblica Dominicana 8
HN - Honduras 8
BY - Bielorussia 7
CY - Cipro 7
ET - Etiopia 7
MD - Moldavia 7
OM - Oman 7
SK - Slovacchia (Repubblica Slovacca) 7
HU - Ungheria 6
MK - Macedonia 6
NG - Nigeria 6
NZ - Nuova Zelanda 6
UY - Uruguay 6
AM - Armenia 5
KZ - Kazakistan 5
NI - Nicaragua 5
PA - Panama 5
PR - Porto Rico 5
PS - Palestinian Territory 5
SN - Senegal 5
CI - Costa d'Avorio 4
HR - Croazia 4
LB - Libano 4
LK - Sri Lanka 4
Totale 52.238
Salva come PNG Salva come JPEG
Città #
Southend 3.859
Ashburn 2.213
Santa Clara 1.990
Singapore 1.889
Stockholm 1.800
Fairfield 1.791
Chandler 1.194
Hong Kong 1.119
Woodbridge 1.107
Houston 1.092
San Jose 972
Hefei 930
Jacksonville 823
Ann Arbor 621
Seattle 608
Wilmington 599
Dearborn 574
Cambridge 568
Nyköping 555
London 554
Beijing 549
Helsinki 469
Rome 420
Los Angeles 392
Milan 384
Ho Chi Minh City 367
Council Bluffs 362
Chicago 354
Seoul 337
Dallas 324
New York 262
The Dalles 258
Modena 251
Hanoi 236
Berlin 212
Izmir 196
San Diego 186
Princeton 181
Sofia 169
Eugene 150
Munich 147
Lauterbourg 142
Buffalo 120
São Paulo 119
Moscow 115
Shanghai 109
Salt Lake City 108
Bologna 103
Naples 97
Orem 91
Bremen 89
Jakarta 89
Toronto 79
Des Moines 77
Phoenix 76
Frankfurt am Main 75
Parma 75
Columbus 72
Palermo 70
Brussels 68
Florence 66
Rimini 66
Montreal 64
Warsaw 64
Tokyo 59
Verona 59
Amsterdam 56
Turin 56
Redwood City 53
Chennai 52
Bari 50
Yalova 50
Denver 49
Dublin 49
Falls Church 49
Atlanta 48
Catania 47
Da Nang 46
Tampa 45
Rio de Janeiro 44
Haiphong 42
Mexico City 42
Johannesburg 41
Boston 39
Brooklyn 39
Elk Grove Village 37
Fremont 37
Guangzhou 36
Manchester 35
Turku 35
Boardman 33
Mumbai 33
Paris 33
Miano 32
Padova 32
San Francisco 32
Poplar 31
Brasília 29
Dhaka 29
Kunming 29
Totale 34.606
Salva come PNG Salva come JPEG
Nome #
Effetti dell’insulina sui livelli di omocisteina plasmatica in pazienti con diabete mellito tipo ii con e senza intolleranza alla metionina 2.521
Alterations in iron status predict cardiac response to blood transfusion in -thalassemia major 1.837
Validating the Body Uneasiness Test (BUT) in obese patients 725
Terapia antialadosteronica e prevenzione della cardiomiopatia cirrotica 712
Weight Loss Expectations in Obese Patients and Treatment Attrition: An Observational Multicenter Study 709
Trombosi portale e iperomocisteinemia in pazienti con cirrosi epatica 677
Isomeri urinari della Coproporfirina in pazienti con Epatopatie Colestatiche Acquisite e sindrome di Dubin-Johnson 599
Oxford Manuale di Medicina Clinica 586
Impiego dei marcatori di neoplasia (CEA, CA 19.9, CA 125, CA 16.3, NSE) in Medinina Interna: uno studio retrospettivo 575
The QUOVADIS Study: features of obese Italian patients seeking treatment at specialist centers 515
Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis 507
04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report 499
04092 Liver function, iron status, and hemopoiesis in erythropoietic protoporphyria (EPP): insights into a complex interplay 489
Hyperhomocysteinaemia in chronic liver diseases: role of disease stage, vitamin status and methylenetetrahydrofolate reductase genetics 484
A challenging diagnosis for potential fatal diseases: Recommendations for diagnosing acute porphyrias 435
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 429
Urinary and plasma homocysteine and cysteine levels during prolonged oral N-acetylcysteine therapy 416
Acute Intermittent Porphyria in a Child with Severe Neuropathy 411
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy 407
Hemolysis and hyperhomocysteinemia caused by cobalamin deficiency: three case reports and review of the literature 403
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a “real life” prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study) 403
Safety and efficacy of sucrosomal iron in inflammatory bowel disease patients with iron deficiency anemia 401
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 387
EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks 379
The Acute Porphyric Attack: A Difficult Diagnosis for a Potential Lethal Event in Emergency Medicine 378
Rhodococcus equi Pneumonia in Kidney Transplant Recipient Affected by Acute Intermittent Porphyria: A Case Report 368
A role for homocysteine increase in haemolysis of megaloblastic anaemias due to vitamin B-12 and folate deficiency: results from an in vitro experience 363
Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis. 360
Serum and Liver Iron Differently Regulate the Bone Morphogenetic Protein 6 (BMP6)-SMAD Signaling Pathway in Mice 354
Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. 351
N-acetyl-cysteine reduces homocysteine plasma levels after single intravenous administration by increasing thiols urinary excretion 347
HYPERHOMOCYSTEINEMIA AND MTHFR C677T POLYMORPHISM IN PATIENTS WITH PORTAL VEIN THROMBOSIS COMPLICATING LIVER CIRRHOSIS 341
IS FLOW-MEDIATED DILATATION (FMD) ASSESSMENT A RELIABLE MARKER OF ENDOTHELIAL DYSFUNCTION IN LIVER CIRRHOSIS? 339
MARKERS OF ENDOTHELIAL DYSFUNCTION AS PREDICTORS OF ASCITIC DECOMPENSATION IN PATIENTS WITH LIVER CIRRHOSIS. 336
Antiviral treatment profoundly affects iron status in HCV patients: Implications for management and treatment outcome 335
Weight Loss Expectations in Obese Patients Seeking Treatment at Medical Centers 332
Hepatocellular Carcinoma in HIV-infected Patients: Check Ealy, Treat Hard 328
Alendronate treatment for osteoporosis in patients infected with human immunodeficiency virus. 328
A large deletion on chromosome 11 in acute intermittent porphyria 325
Red wine consumption prevents vascular oxidative stress induced by a high-fat meal in healthy volunteers 323
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 322
The Metabolic Syndrome in Treatment-Seeking Obese Persons 317
Psychological Distress in Morbid Obesity in Relation to Weight History 317
Drugs and acute porphyrias: reasons for a hazardous relationship 317
ANTIALDOSTERONE THERAPY IN LIVER CIRRHOSIS: A ROLE FOR PREVENTION OF CIRROTHIC CARDIOMIOPATHY? 315
Antialdosterone therapy in liver cirrhosis: a role for prevention of cirrhitc cardiomiopathy ? 313
Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease. 310
Tumour markers in internal medicine: a low-cost test or an unnecessary expense? A retrospective study based on appropriateness 308
MTHFR C677T polymorhism and hyperhomocysteinemia in patients with liver cirrhosis complicated by portal vein thrombosis and hepatocellular carcinoma 306
Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians 305
HIV INFECTION AND SURVIVAL IN PATIENTS WITH HCCAND LIVER CIRRHOSIS 304
Molecular characterization, by digital PCR analysis of four HMBS gene mutations affecting the ubiquitous isoform of Porphobilinogen Deaminase (PBGD) in patients with Acute Intermittent Porphyria (AIP) 302
Anti- and pro-oxidant factors and endothelial dysfunction in chronic cigarette smokers with coronary heart disease 301
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad? 300
EXPLORE: A prospective, multinational natural history study of acute hepatic porphyria patients with recurrent attacks 298
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 298
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 294
Clinical, biochemical and genetic characteristics of Variegate Porphyria in Italy 294
Weight cycling in treatment-seeking obese persons: data from the QUOVADIS study 291
Radiofrequency ablation combined with transcatheter arterial chemioembolization in the treatment of advanced hepatocellular carcinoma 290
Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives 289
Pro-oxidant and antioxidant factors in acute intermittent porphyria: Family studies 286
Continuous combined hormone replacement therapy with oral 17β-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women 283
Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy 281
Urinary coproporhyrin isomers during therapy with IFn-RIBA in patients with chronic hepatitis due to HCV infection 281
Affinità dell'omocisteina per le lipoproteine 281
Flow-mediated dilatation (FMD) assessment as a marker of endothelial dysfunction in liver cirrhosis 279
Role of Multidrug-Resistance Protein 2 in coproporphyrin transport: results from experimental studies in bile fistula rat models 277
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C 277
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) 271
Prevention of a first episode of variceal bleeding: role of duplex Doppler sonographic measurement of the acute response to beta-blockers. 270
Guidelines for the management of acute porphyria: recommendations from the International Porphyria Network 267
THE MOLECULAR BASIS FOR THE HEPATIC REGULATION OF HEPCIDIN, THE IRON HORMONE, BY BONE MORPHOGENETIC PROTEINS. 265
The Effect of Obesity Management on Body Image in Patients Seeking Treatment at Medical Centers 264
Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects 263
Relevance of different apolipoprotein content in binding of homocysteine to plasma lipoproteins 261
Parametri predittivi e risposta sostenuta alla terapia antivirale combinata nell'epatite cronica attivva HCV correlata (ECA HCV) 260
Snoring, hypertension and Type 2 diabetes in obesity. Protection by physical activity 260
Portal vein thrombosis and thrombophilia in liver cirrhosis: a role for hyperhomocysteinemia ? 259
Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats 256
A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review 255
Correlation between plasma malonyldialdeide levels and paroxonase activity in healthy subjects and in patients with atherosclerotic disease 254
Serum endothelin-1 as predictor of ascitic decompensation in patients with liver cirrhosis 253
THE INTERACTION OF BILIAR ACIDS WITH 2-HYDROXYPROPYL-CYCLODEXTRIN IN SOLUTION AND IN THE SOLID STATE 251
Rilevanza del diverso contenuto apolipoproteico nel legame dell’omocisteina alle lipoproteine 250
Acute Hepatic Porphyrias: “Purple Flags”—Clinical Features that should Prompt Specific Diagnostic Testing 249
Does the measurement of portal flow velocity have any value in the identification of patients with cirrhosis at risk of digestive bleeding ? 247
Ataxia-myoclonus syndrome in patients with SARS-CoV2 infection 246
Peroxidation indices and total antioxidant capacity in plasma during hyperhomocysteinemia induced by methionine oral loading 245
Recovery of chronic motor neuropathy due to acute intermittent porphyria after givosiran treatment in a young boy: a case report 244
Alendronate for the treatment of Osteoporosis in HIV-infected patients. 244
Improvement of survival in patients with intermediate stage (BCLC-B) hepatocellular acrcinoma complicating liver cirrhosis by combination therapy with radiofrequency ablation and transcatheter chemioembolization 244
Sarcoma primitivo del cuore. Descrizione di un caso 243
Distribution of homocysteine in plasma lipoproteins 240
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria 240
Iron Metabolism in the Disorders of Heme Biosynthesis 239
Plasma nitric oxide production during acute hyperhomocysteinemia in atherosclerotic patients and controls 239
Markers of Endothelial Dysfunction in patients with liver cirrhosis with anh without portal hypertension 238
Impact of nutrition on cognition and affectivity in the elderly: A review 237
Construct Validity of the Short Form-36 Health Survey and Its Relationship with BMI in Obese Outpatients 237
Totale 37.441
Salva come PNG Salva come JPEG
Categoria #
all - tutte 172.824
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 172.824
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.491 0 412 290 308 143 217 211 219 407 316 538 430
2022/20234.119 423 420 318 370 452 551 118 389 491 112 229 246
2023/20242.739 168 179 241 227 399 196 225 336 115 124 192 337
2024/20258.142 322 149 325 583 1.543 1.083 598 494 885 337 858 965
2025/202617.715 1.010 748 1.368 1.491 1.785 1.117 1.782 828 3.445 1.625 1.487 1.029
2026/20271.027 1.008 19 0 0 0 0 0 0 0 0 0 0
Totale 52.593